ClinConnect ClinConnect Logo
Search / Trial NCT06397365

Effect of Hypnosis on Adherence to Continuous Positive Airway Pressure.

Launched by SOLELHAC GEOFFROY · Apr 30, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Cpap Adherence Medical Hypnosis Obstructive Sleep Apnea

ClinConnect Summary

This clinical trial is studying whether medical hypnosis can help patients stick to their Continuous Positive Airway Pressure (CPAP) therapy for sleep-disordered breathing, which includes conditions like obstructive sleep apnea. CPAP is a common treatment that helps keep airways open during sleep, but many patients struggle to use it effectively. The researchers believe that hypnosis might improve how patients feel about their treatment and encourage them to use the CPAP machine more consistently.

To participate in the trial, you need to be at least 18 years old and have been prescribed CPAP therapy but are currently using it for less than 3 hours a night on average. You also need to be willing to try hypnosis as part of the study. If you join, you can expect to learn self-hypnosis techniques that may help you feel more comfortable with your CPAP treatment, potentially leading to better sleep and overall health. The trial is currently recruiting, so if you or someone you know is having difficulty with CPAP, this might be an opportunity to explore a new approach.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ≥ 18 years of age
  • Indication for long-term CPAP treatment for sleep-disordered breathing.
  • Intolerance of CPAP with use of less than 3h/night on average (assessed at the second CPAP check-up by the home care provider 1 to 3 months CPAP introduction).
  • Ability to provide informed consent.
  • Exclusion Criteria:
  • Patient's refusal to experience hypnosis.

About Solelhac Geoffroy

Solelhac Geoffroy is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. With a strong commitment to enhancing patient outcomes, the organization specializes in the design, management, and execution of clinical trials across various therapeutic areas. Leveraging a robust network of experts and state-of-the-art methodologies, Solelhac Geoffroy focuses on ensuring the highest standards of compliance and scientific rigor. Their mission is to facilitate the development of safe and effective therapies, ultimately contributing to the improvement of global health.

Locations

Lausanne, Vaud, Switzerland

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported